Stay informed with expert insights, trends, and best practices in life sciences compliance.
In today’s intricate regulatory environment, compliance isn’t just a requirement—it’s a dynamic challenge that demands a data-driven compliance solution. This article explores the transformative power of data in monitoring regulatory compliance within organizations. From adhering to stringent regulations such as the anti-kickback statute to OIG’s special fraud alert to identifying key risk areas within the […]
Chief Compliance Officers (CCOs) play a vital role in ensuring that organizations operate within the bounds of the law and adhere to regulatory and industry standards. They are responsible for leading and implementing effective compliance strategies and programs that mitigate legal and reputational risks. The appointment of CCOs to senior positions within organizations reflects the […]
Regulatory demands for life sciences companies have evolved significantly over the years. In the past, regulations were primarily focused on product safety and efficacy. However, today, regulations also encompass many other areas, such as reporting all transactions to the Center for Medicare and Medicaid Services (transparency reporting), ensuring compliant third-party engagements, and more. Combined with […]
As the Life Sciences industry evolves, the significance of robust data collection processes cannot be overstated, especially when submitting open payment data to the Centers for Medicare & Medicaid Services (CMS). With regulatory scrutiny on the rise, organizations grapple with the complexities of ensuring their spend reporting practices align with the ever-evolving compliance requirements. As […]
The importance of adhering to regulatory demands continues an upward trend. Life science compliance is becoming more complex with heightened regulatory demands and evolving rules and regulations. With compliance programs playing a crucial role in risk identification, management, and remediation, leveraging a data-driven compliance solution to augment compliance program capabilities seems to be the way […]
Life sciences companies continue introducing novel therapies, treatments, and new scientific discoveries, such as Abbvie’s hepatitis C treatment Mayvret, for treating patients without cirrhosis and with compensated cirrhosis. However, changing regulations, heightened scrutiny, and regulatory expectations have impacted life sciences companies and compliance professionals. The impact came with both challenges and opportunities for compliance professionals. […]